John R. Liddicoat - 28 May 2021 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & President of Americas
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
28 May 2021
Net transactions value
-$1,522,258
Form type
4
Filing time
01 Jun 2021, 17:55:29 UTC
Next filing
04 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Options Exercise $1,333,410 +17,095 +40% $78.00 59,646 28 May 2021 Direct F1, F2
transaction MDT Ordinary Shares Options Exercise $100,074 +1,283 +2.2% $78.00 60,929 28 May 2021 Direct F1
transaction MDT Ordinary Shares Options Exercise $100,036 +1,136 +1.9% $88.06 62,065 28 May 2021 Direct F1
transaction MDT Ordinary Shares Options Exercise $1,333,405 +15,142 +24% $88.06 77,207 28 May 2021 Direct F1
transaction MDT Ordinary Shares Sale $4,389,182 -34,656 -45% $126.65 42,551 28 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -17,095 -100% $0.000000* 0 28 May 2021 Ordinary Shares 17,095 $78.00 Direct F1, F3
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -1,283 -100% $0.000000* 0 28 May 2021 Ordinary Shares 1,283 $78.00 Direct F1, F3
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -1,136 -100% $0.000000* 0 28 May 2021 Ordinary Shares 1,136 $88.06 Direct F1, F3
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -15,142 -100% $0.000000* 0 28 May 2021 Ordinary Shares 15,142 $88.06 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 This balance increased by 562 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan.
F3 These options become exercisable at the rate of 25% of the shares granted per year beginning one year from grant date.